Utah Medical Products/$UTMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Utah Medical Products
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
Ticker
$UTMD
Sector
Primary listing
Employees
161
Headquarters
Website
UTMD Metrics
BasicAdvanced
$200M
16.69
$3.74
0.32
$1.22
1.95%
Price and volume
Market cap
$200M
Beta
0.32
52-week high
$68.16
52-week low
$51.26
Average daily volume
12K
Dividend rate
$1.22
Financial strength
Current ratio
41.87
Quick ratio
38.071
Long term debt to equity
0.218
Total debt to equity
0.218
Dividend payout ratio (TTM)
32.72%
Profitability
EBITDA (TTM)
16.868
Gross margin (TTM)
57.33%
Net profit margin (TTM)
32.33%
Operating margin (TTM)
35.98%
Effective tax rate (TTM)
18.93%
Revenue per employee (TTM)
$240,000
Management effectiveness
Return on assets (TTM)
6.96%
Return on equity (TTM)
10.39%
Valuation
Price to earnings (TTM)
16.688
Price to revenue (TTM)
5.395
Price to book
1.71
Price to tangible book (TTM)
1.98
Price to free cash flow (TTM)
15.183
Free cash flow yield (TTM)
6.59%
Free cash flow per share (TTM)
4.116
Dividend yield (TTM)
1.94%
Forward dividend yield
1.95%
Growth
Revenue change (TTM)
-16.64%
Earnings per share change (TTM)
-13.57%
3-year revenue growth (CAGR)
-8.83%
10-year revenue growth (CAGR)
-0.62%
3-year earnings per share growth (CAGR)
-4.97%
10-year earnings per share growth (CAGR)
2.16%
3-year dividend per share growth (CAGR)
11.99%
10-year dividend per share growth (CAGR)
9.18%
UTMD Financial Performance
Revenues and expenses
UTMD News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept17
Utah Medical Products
DividendEx-dividend
Oct2
Utah Medical Products
DividendPayment
$0.305Per share
FAQs
What’s the current market cap for Utah Medical Products stock?
Utah Medical Products (UTMD) has a market cap of $200M as of September 16, 2025.
What is the P/E ratio for Utah Medical Products stock?
The price to earnings (P/E) ratio for Utah Medical Products (UTMD) stock is 16.69 as of September 16, 2025.
Does Utah Medical Products stock pay dividends?
Yes, the Utah Medical Products (UTMD) stock pays dividends to shareholders. As of September 16, 2025, the dividend rate is $1.215 and the yield is 1.95%. Utah Medical Products has a payout ratio of 32.72% on a trailing twelve-month basis.
When is the next Utah Medical Products dividend payment date?
The next Utah Medical Products (UTMD) dividend payment is scheduled for October 02, 2025.
What is the beta indicator for Utah Medical Products?
Utah Medical Products (UTMD) has a beta rating of 0.32. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.